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Abstract
In a series of experiments the welfare of para-aminovalerophenone (PAVP) sub-lethally poisoned rats (Rattus norvegicus) was
assessed. The experiments: (i) examined the acute methaemoglobin (MetHb) profile over time; (ii) refined the LD50 estimate for
PAVP in adult female rats; (iii) developed and validated three neurological tests; and (iv) assessed rats for neurological deficit following
prolonged methaemoglobinaemia. The results from the first three experiments were used to refine the sub-lethal study. In the sub-
lethal experiment 20 rats were gavaged with a single dose of 40 mg kg–1 PAVP (based on an LD50 estimate of 43.3 mg kg–1). Control
rats (n = 10) were treated with the carrier only. Eleven (surviving) PAVP-treated rats and controls were assessed over a two-week
period. Rats were tested for forelimb grip strength, stability on an inclined plane and the ability to remove tape wrapped around a
forepaw in order to determine deficits in motor functions and sensorimotor integration. Signs of recovery began 3–6 h post-dosing,
with all animals showing no outward signs of poisoning within 48 h, and over the 14-day post-treatment monitoring period they gained
weight and increased their food consumption. There was no significant overall difference in performance between PAVP-treated and
control rats in any of the three neurological tests. In the inclined plane test, performance of sub-lethally PAVP-poisoned rats appeared
to be temporarily impaired with treated animals slipping at a lower angle than controls on day two. During the tape removal test,
four PAVP-treated rats failed to remove the tape within the 3-min time limit on one occasion each (4/77 occasions) up to seven days
post-dosing. The severity and duration of signs following acute sub-lethal PAVP poisoning appeared to be lower than those reported
for existing rodenticides. It is likely that the results presented in this study extend to other MetHb-inducers.
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Introduction
Vertebrate pesticides are used to control pests, such as rats
(Rattus spp), mice (Mus musculus) and other non-native
animals in order to reduce damage to crops and property,
prevent the spread of disease, reduce public nuisance and
conserve native species. For rodent control, poison
baiting is often preferred to other methods, such as
trapping, on grounds of cost-effectiveness, but many of
the poisons currently on the market are under frequent
scrutiny due to concerns about humaneness and non-
target effects. For example, the nature and duration of
signs of poisoning and the time to death caused by antico-
agulant poisons and the non-anticoagulant calciferol
(cholecalciferol), have led to these pesticides being
considered markedly inhumane (PSD 1997; Littin et al
2002; Mason & Littin 2003; Fisher et al 2010). A
commonly used alternative, zinc phosphide, kills quicker
and thus could be considered relatively more humane
(PSD 1997; Mason & Littin 2003; Ross & Henderson
2006; Eason et al 2013). However, the withdrawal of non-
anticoagulant rodenticides, including zinc phosphide and
calciferol, from some markets has led to even more
reliance upon the use of anticoagulants. With the aim of
improving humaneness and minimising the risk to non-
target species without compromising efficacy, new bait
formulations and novel vertebrate pesticides are being
developed (Eason et al 2008). 
One group of novel pesticides targets red blood cells in
mammalian pests and induces the formation of methaemo-
globin (MetHb), which at high concentrations leads to rapid
and lethal hypoxia in the brain and heart, resulting in
animals becoming lethargic and unconscious prior to death
(Vandenbelt et al 1944). The potential of one particular
MetHb-inducing chemical, para-aminopropiophenone
(PAPP), as a vertebrate control agent has been investigated
(Saverie et al 1983) and more recent research has demon-
strated the efficacy of PAPP against non-native cats
(felis catus silvestris), foxes (Vulpes spp) and stoats
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(Mustela erminea) in Australia and New Zealand (Marks
et al 2004; Fisher et al 2005; Murphy et al 2011). While
PAPP appears to be relatively toxic to carnivores, it is less
toxic to rodents: Scawin et al (1984) reported oral LD50
values of 474 and 223 mg kg–1 to male and female labora-
tory (Porton-Wistar strain) rats, respectively. Durie and
Doull (1968) found similar intraperitoneal LD50 values for
males and females but marked differences between strains
(273 and 85 mg kg–1 for Holtzman and Charles River
strains, respectively). For practical rodent control, poisons
that fail to kill at 100 mg kg–1 are unlikely to make effective
rodenticides (EPPO 1982). However, research reviewed by
Baskin and Fricke (1992) investigated the use of PAPP as a
cyanide antidote and also examined structural analogues to
find compounds that had a greater half-life for the formation
of MetHb in blood and therefore prolonged protection
against cyanide. One particular analogue, PAVP (para-
aminovalerylphenone, also referred to as para-amino-
valerophenone) appeared to be able to maintain MetHb
levels in mouse blood longer than PAPP and thus might
make a more effective acute rodenticide. Pan et al (1983)
tested PAPP and four analogues and found an inverse rela-
tionship between the length of the alkyl chain and oral
LD50 values in laboratory rats and mice: using propylene
glycol as a carrier, PAVP LD50 in Sprague-Dawley male
rats was 84 mg kg–1 compared with 221 mg kg–1 for PAPP.
More recently, Rennison et al (2013) reported similar LD50
values of 85 mg kg–1 in rats. While the toxicity of PAVP
appears to be relatively low compared with other estab-
lished acute rodenticides, the prospect of an improvement in
the welfare of target animals during poisoning makes
further consideration worthwhile.
The evaluation of compounds as potential rodenticides
typically begins with an estimation of toxicity in the form of an
LD50 test (Bentley 1958). Although the LD50 test is now
outdated for standard toxicological testing, it is still the standard
measure of toxicity used in the development and registration of
pesticides around the world. The LD50 test allows comparisons
to other toxicants that are designed to kill pest species. In a
number of countries, including New Zealand, the UK and USA,
the LD50 is a mandated test of toxicity when producing the
dossiers for registration of new toxicant agents. Initially in
toxicity testing, small numbers of animals are used so that
compounds insufficiently toxic or regarded as inhumane can be
quickly excluded. Thereafter, more animals may be tested and
in addition to refining the toxicity estimate, further assessments
of the humaneness of the poisoning process can be made. The
nature of the test means that assessments can be carried out not
only on animals that die but also on those that recover. The
work reported here concerns the latter. Acute sub-lethal
poisoning can range from largely asymptomatic for animals
receiving very small doses to the development of severe signs
in individuals ingesting a near-fatal dose. In the latter case, the
humaneness of a poison may become questionable if the
severity of the signs leads to a slow recovery or, at worst,
permanent damage. As MetHb-inducers result in an oxygen
deficit in the brain, the likelihood of temporary or permanent
brain damage in survivors could be a concern. While damage
resulting in paralysis or severe loss of co-ordination, for
instance, would most likely be detected during initial screening
of the compound, subtle changes in behaviour might be missed
during casual observations of an animal. Apparent full recov-
eries from PAPP intoxication within 1–2 days post-dosing were
reported in stoats, ferrets (Mustela furo), brushtail possums
(Trichosurus vulpecula), tammar wallabies
(Macropus eugenii), and mallards (Anas platyrhynchos) (Fisher
et al 2005, 2008; Fisher & O’Connor 2007). However, no
neurological tests were carried out in these cases and the degree
of methaemoglobinaemia was not determined.
In humans, clinical cyanosis is seen at MetHb concentrations
of 15–20%, but patients are usually asymptomatic; concentra-
tions of 20–45% induce dyspnoea and lethargy and at 45–55%
there is increasing depression in the level of consciousness
and at 55–70% there are major hypoxic symptoms (associated
with circulatory failure and cardiac arrhythmias) (Hall et al
1986). The consequences of sub-lethal poisoning on the long-
term welfare of rats are thus expected to be seen, if they occur,
at concentrations above 45%. Detecting neurological damage
that may be non-specific and unpredictable is likely to require
more than one test to monitor brain functions. A number of
tests have been used to examine neurological deficits in foetal
hypoxia and stroke-based rodent models, including grip
strength, inclined plane and tape removal (eg Aronowski et al
1996; Reglödi et al 2003; Lubics et al 2005). Grip strength
tests have been developed to assess the hind limb extensor
response and forelimb grip strength for detecting reduced
motor power (Meyer et al 1979). The inclined plane test deter-
mines a rat’s ability to maintain its equilibrium as well as
assessing strength in the limbs (Rivlin & Tator 1977). The tape
removal test assesses deficits in sensorimotor integration
(Albertsmeier et al 2007). 
This study monitored the recovery of rats from acute sub-
lethal poisoning by PAVP as part of a general assessment of
the humaneness of this potential rodenticide. The first step
was to determine a MetHb profile in rats dosed with PAVP so
that any effects observed could be related to a peak MetHb
level that exceeded 45%. The next step was to obtain a reliable
LD50 estimate in order that the dose administered in the last
stage would be high enough to achieve the minimum MetHb
level, yet low enough to ensure sufficient survivors without
using excessive numbers of animals. The last stage was to
compare the responses of survivors during a series of neuro-
logical tests with those of untreated controls given the same
tests. It is expected that the nature of the sub-lethal effects
would be similar for other MetHb-inducing agents.
Materials and methods
A series of experiments were performed to examine the
behaviour, duration and the nature of the effects of PAVP
sub-lethal poisoning of rats. The experiments: (i)
examined the acute MetHb profile over time; (ii) refined
the LD50 estimate for PAVP in adult female rats; (iii)
developed and validated three neurological tests; and (iv)
assessed rats for neurological deficit following
prolonged methaemoglobinaemia.
© 2015 Universities Federation for Animal Welfare
Sub-lethal effects of methaemoglobinaemia in rats   429
Study animals
All tests were carried out using adult female Wistar rats
(Rattus norvegicus) obtained from a commercial supplier.
Although a full toxicity profile for PAVP in rats has not yet
been established, there is some evidence that males might
be less susceptible to para-aminophenones (Scawin et al
1984; Bright et al 1987). It was therefore expected that the
female response would be less variable.
Animals were housed in plastic cages in groups of two to
three and allowed to acclimatise to laboratory conditions
(12:12 h; light:dark cycle) for at least one week before
experimentation. Rats were offered a standard laboratory
rodent diet ad libitum throughout the trial except prior to the
day of dosing when all food was removed overnight and
new bedding provided (15/30 of the rats in the LD50 exper-
iment were not fasted); water was available ad libitum. All
procedures were carried out under the provisions of the
Animals (Scientific Procedures) Act 1986 and with the
approval of the institute’s Ethical Review Process.
Dosing
PAVP was synthesised at the University of Auckland, New
Zealand. Purity (> 99%) was demonstrated by 1H and 13C
Nuclear Magnetic Resonance (NMR). A concentrate was
prepared by dissolving PAVP in a 9:1 (by weight) mixture
of polyethylene glycol 200 (PEG) and triethanolamine
(TEA) at the rate of 100 mg ml–1. Once dissolved, the
solution was diluted with appropriate amounts of PEG
according to the dose required. Solutions were prepared the
day before dosing and stored at room temperature overnight
prior to use. Animals were orally gavaged at a dose-volume
rate of 5 ml kg–1 bodyweight. Dosing was carried out 3–4 h
after the beginning of the light period. 
LD50 test
A preliminary LD50 estimate (of 30–50 mg kg–1) was
obtained in adult female rats, and refined for a total of 30 rats
by administration of four equally spaced doses (by oral
gavage) between 20 and 50 mg kg–1. The mean bodyweight of
the rats was 235 g (range 210–274 g). Half of the 30 rats were
fasted overnight before dosing. Rats were monitored contin-
uously by direct observation under white lighting for the first
3 h and then at 30-min intervals up to 6 h post-dosing.
Methaemoglobin profile
To determine the acute profile of methaemoglobinaemia
following PAVP administration, 17 fasted rats (mean body-
weight 220 g [range 203–250 g]) were dosed at 30 mg kg–1
(the lower preliminary LD50 estimate) and individuals were
killed by cervical dislocation at 15, 30, 60, 90 and 240 min
post-dosing. Post mortem blood samples were collected in
pre-heparinised syringes (0.1 ml heparin, 500 IU ml–1 units)
(Multiparin, Heparin Sodium, CP Pharmaceuticals Ltd,
Wrexham, UK). Methaemoglobin concentrations were
measured with a CO-oximeter (GEM OPL, Instrumentation
Laboratory Ltd, Warrington, UK) and the mean of three
readings was taken as the response variable. After dosing,
rats were monitored continuously under white lighting.
Neurological tests
Before the tests were used on treated rats, preliminary trials
were carried out to develop the protocol and to ensure that
consistent results would be obtained on at least two separate
occasions when applied to normal animals. For these trials, ten
rats were used with a mean bodyweight of 219 g (range
204–236 g). Rats were subjected to each test over four consec-
utive days. The reproducibility of the results for each test was
assessed by the calculation of an intra-class correlation coeffi-
cient (ICC) for a two-way design with ‘rats’ as a random
variable and ‘days’ as a fixed variable. Intra-class correlation
coefficients were calculated using SPSSv19 (IBM, Chicago,
USA) and interpreted according to the methods of Shrout and
Fleiss (1979) and McGraw and Wong (1996).
Grip strength
The apparatus used to measure grip strength consisted of a
steel T-bar grasping device which was connected to a strain
gauge (sampling rate of 1,000 Hz) that was mounted onto a
weighted stand (BioSeb, Vitrolles, France). Rats were held
around the body and the test measurement was made by
allowing the animal to grasp the T-bar with its forepaws and
then slowly pulling it away horizontally until its grip was
broken. For consistency, a standard procedure was used, with
a minimum of operator changeovers (operators were not
changed within days). The response variable was the mean of
three readings of the force (measured in g) at which release
from the bar occurred. Intra-class correlation coefficients for
single and average measures were 0.3 and 0.7, respectively.
Inclined plane
The apparatus consisted of an oblong transparent box
(50 × 19.5 × 40 cm; length × width × height) with a floor that
could be raised at one end to give an inclined plane with
angles from 30–90°. The floor consisted of a Perspex™ sheet
covered with the plastic film that the manufacturer used to
protect the surface. Each rat was placed on the floor with its
body axis parallel to the inclined plane. The floor was slowly
raised from one end until the rat began to slip
downwards — the angle at which this occurred was recorded.
Between tests, the floor was wiped clean of urine and faeces
in order to maintain the friction coefficient. The starting angle
of the floor was 30° and the rat was placed ¾ of the way up
the raised floor (Yonemori et al 1998), the endpoint was set
at 70°. Three readings were taken and averaged to produce
the response variable. The angle at which a comatose rat
would slip (determined by testing a freshly dead rat) was
found to be 22°. Intra-class correlation coefficients for single
and average measures were 0.2 and 0.5, respectively. 
Tape removal
Each rat was placed into a Perspex™ square arena
(40 × 40 × 40 cm) with the back and sides covered with white
paper to prevent distractions. Each animal was allowed a
familiarisation period of 5 min or until it started grooming
(whichever occurred first). The rat was then removed and a
15 × 10 mm (length × width) piece of adhesive surgical tape
(Durapore™, 3M Health Care Ltd, Loughborough, UK) was
wrapped around the toes of the left forepaw ensuring that the
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edges of the tape did not stick together. It was then returned
to the arena and the time (s) taken to remove the tape
recorded. The results were consistent with those reported in
the literature (eg Albertsmeier et al 2007) in that most rats
removed the tape in about 20 s (the endpoint for the test was
180 s). Intra-class correlation coefficients for single and
average measures were 0.7 and 0.9, respectively. 
Neurological tests on survivors
To determine sub-lethal effects, 20 rats were dosed by oral
gavage with 40 mg kg–1 PAVP (based on the results of the
LD50 test) and ten rats were dosed with the carrier only
(PEG/TEA). On the day of dosing the rats weighed
175–217 g (mean 193 g). After dosing, the rats were
monitored continuously by direct observation under white
lighting for the first 3 h and then at 30-min intervals up to
6 h post-dosing. The behaviour of the rats was directly
observed and recorded using the protocol as described in a
companion paper (Gibson et al 2015; this issue). However,
due to inaccuracies in the recording sequences, the data are
presented as changes in generalised signs of methaemoglo-
binaemia for all treated rats.
Seven rats in the treated group died between 5 min and 6 h
post-dosing and another two died overnight (ie 6 < x < 24 h
post-dosing). None of the control rats died. The eleven
surviving rats in the treated group and the ten controls were
subjected to the neurological tests on 1, 2, 4, 7, 9, 11 and
14 days post-treatment. The tests were performed as
described in the validation trials above in the order: tape
removal, grip strength, inclined board. To minimise a
possible test-sequence effect, on each of the seven days that
the tests were conducted, the order in which the rats were
tested, by cage, was reversed. Additionally, a subjective
(appearance and health) score was devised to assess the
overall condition of each rat on each day the tests were
carried out: ‘0’ normal; ‘1’ normal apart from a colour differ-
ence (ie bluish tinge to ears and feet, eye colour pale); ‘2’
some abnormal/unusual behaviour (eg long periods of rest in
between periods of activity); ‘3’ obviously abnormal/unusual
behaviour (ie mostly inactive, hunched appearance, staring
coat, unsteady gait); ‘4’ moribund or comatose. The assess-
ment was carried out during the familiarisation period at the
beginning of the tape removal test. Also, 24-h food consump-
tion (by cage) was recorded pre-treatment (day 0) and on
days 4 and 11 post-treatment. Individual bodyweights were
recorded pre-treatment (day 0) and post-treatment on days 3,
10 and 14. Data were analysed using repeated measures
mixed models (REML) in Genstat v16.1 (VSN International,
Hemel Hempstead, UK) to examine the effect of time and
treatment on bodyweight and food consumption. At the end
of the trial (day 14), blood MetHb levels were measured with
a CO-oximeter in three treated and two control rats, which
were dispatched by neck dislocation.
For the tape removal test, the total time for each rat to remove the
tape was split into two periods: the time (s) until the animal began
to remove the tape (latency) and the actual time taken to remove
it. If a rat failed to complete the task within the designated
maximum period (3 min), a default value of 180 s was recorded
(Albertsmeier et al 2007). Each period was analysed separately. 
An analysis of the data from the neurological tests was
made using linear mixed models for repeated measurements
with time (post-treatment days) and treatment as fixed
effects. The covariance structure that gave the lowest AIC
value (Akaike’s Information Criterion) was used. The
Mann-Whitney U test was used to examine for differences
in performance between treated and control rats on the
inclined board test for each day. Analyses were carried out
using SPSSv19 (IBM, Chicago, USA) or Genstat v16.1
(VSN International, Hemel Hempstead, UK). 
Results
LD50 test
Based on 30 animals, the calculated LD50 was
43.3 mg kg–1 (95% fiducial limits 37.4–68.5). There was
no anecdotal evidence of any difference in response, such
as time to onset of signs of methaemoglobinaemia,
between animals that were fasted overnight before test and
those that were not. Based on these results, 40 mg kg–1 was
used as the dose for the sub-lethal experiment with the
expectation, from the MetHb profile trial results, that the
MetHb level in surviving rats would exceed 45%.
Subsequently, incorporating the additional data from the
20 rats dosed with 40 mg kg–1, the revised LD50 estimate
of 43.3 mg kg–1 was further refined to 42.2 mg kg–1 (95%
fiducial limits 38.2–55.4 mg kg–1). The LD98 was
69.9 mg kg–1 (54.1–387.6 mg kg–1).
Methaemoglobin profile 
At a dose of 30 mg kg–1, MetHb levels peaked between 30 and
60 min post-dosing and remained high for at least another 3 h
(Figure 1). In rats surviving to their designated time-point, the
minimum level recorded was 55%. One rat in the 90-min group
died after 71 min with 81% MetHb and a second in the 240-
min group died at 105 min post-dosing (MetHb level not
obtained). At the 90-min point, two rats with 56 and 59%
MetHb, respectively, displayed signs of methaemoglobinaemia
(cyanosis, lethargy) but were fully responsive to auditory (click
noise of ≈79 dB) and visual stimuli (threat response of rushing
hand to the face); two animals with the highest levels (76, 77%)
were recumbent and mostly unresponsive. Of the two rats that
survived 240 min post-dosing, one with 67% MetHb was fully
responsive to stimuli, drinking normally and able to move
around the cage, while the other with 76% MetHb was
comatose (no righting response, no blinking response after
touching the cornea, no tail pinch reflex).
Observations on sub-lethally poisoned rats
After dosing with PAVP the rats showed similar signs of
MetHb intoxication as reported by Gibson et al (2015; this
issue), with the first (acute) signs apparent within 5 min; this
included pale ears, feet and tail and a darkening of the eyes,
which were all easily discernible in the albino rat. The feet, in
particular, quickly developed a bluish tinge as cyanosis
progressed. The animals’ movements then rapidly slowed and
after 20–30 min the rats became recumbent with the head and
body upright, but resting on the floor with the feet underneath
(sternal recumbency); breathing became abnormal.
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Thereafter, in the recording periods 3–6 h post-dosing, some
animals were occasionally observed moving sluggishly
around the cage or repositioned themselves on the same spot.
The majority of rats were not seen eating or drinking 3–6 h
post-dosing. The speed of recovery varied considerably with
some individuals showing distinct signs after 3 h, such as
resuming a normal posture with the head and body off the
ground and resuming drinking and eating. Others did not
show these signs for 6 h post-dosing and 4/11 surviving
treated rats were noted as ‘lethargic’ 24 h post-dosing.
However, within 48 h, all treated rats seemed normal in
appearance and mobility. Using the subjective appearance
and health scoring system, all control rats were rated as ‘0’
(normal) on all days; for the treated group, on day one, one
treated rat was rated ‘0’, six rats were ‘1’, two were ‘2’ and
two were ‘3’. From day two on, all treated rats were rated as
‘0 ’. Blood MetHb levels on day 14 in the three treated rats
and two control rats tested were ≤ 0.3 and 0%, respectively.
Neurological tests
Tape removal
Results of the tape removal test are presented in Figures 2
and 3. All control rats removed the tape on all days. Four
treated rats failed to remove the tape within the time limit;
two on day one, one on day four and another on day seven.
One of the treated rats that failed to remove the tape (on day
one) did not attempt to remove the tape within 3 min; the
other three attempted to remove the tape but did not
complete the task within the time limit. No effect of
treatment on latency to remove the tape (P = 0.329)
(Figure 2) or tape removal time was (P = 0.111) (Figure 3)
was detected. Over the 14 days of the trial, there was a
significant reduction in latency to remove the tape
(P < 0.001) and tape removal time (P < 0.001) but no
day × treatment interaction for latency to remove the tape
(P = 0.827) or tape removal time (P = 0.776).
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Figure 1
Time profile of methaemoglobin level in
rats from 15 to 240 min (4 h) after dosing
with 30 mg kg–1 PAVP. Each bar shows the
value for an individual rat. One rat in the
90-min group died at 71 min with a MetHb
level of 81% and another in the 240-min
group at 105 min (level not obtained).
Figure 2
Median latency (± median absolute deviation
[MAD]) (s). Latency was the time taken to
begin to remove a piece of tape applied to
the front paw. 
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Grip strength 
There was no significant difference between treatment and
control groups or evidence of trend in time. The pull required
to break the grip of control rats varied between 145.1–553.7 g
compared with 136.6–713.7 g for treated rats (Figure 4). 
Inclined board
On day one, control rats slipped when the board was raised to
a mean (± SEM) angle of 53.7 (± 1.4)° compared with
50.7 (± 2.2)° for treated rats. By day 14, these mean angles had
increased to 60.3 (± 2.7) and 61.5 (± 1.2)° for control and
treated animals, respectively (Figure 5). There was a trend over
time for both groups of rats to hold at a steeper angle before
slipping (P < 0.001), ie there was an improvement in perform-
ance of both groups over the 14 days. There was no overall
difference due to treatment (P = 0.5). However, there was a
near significant interaction between treatment and day of
treatment (P = 0.055) suggesting that the performance of the
treated group was lower than that of controls initially, but there
was convergence in performance over time. The performance
of treated rats was impaired relative to controls on day two
(P = 0.013) but not on any other test days (P > 0.10).
Bodyweight and food consumption
Over the 14-day monitoring period, there was a significant
increase in both bodyweight (P < 0.001) and food consump-
tion (P = 0.006) but no difference between treated and control
groups (P = 0.301 and P = 0.076 for bodyweight and food
consumption, respectively). There was a significant interac-
tion between time and treatment for food consumption
(P = 0.050), indicating that the difference between treated and
control groups changed over time; food consumption for
treated rats appeared to be suppressed relative to controls on
day four post-dosing, but then recovered by day 11 (Figure 6).
© 2015 Universities Federation for Animal Welfare
Figure 3
Median time (± median absolute deviation
[MAD]) (s) taken by rats to completely
remove the tape attached to one
forepaw.
Figure 4
The mean (± SEM) pull required to break
the grip of rats holding with their
forepaws onto a T-bar attached to a
strain gauge.
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Discussion
The effects of pesticide ingestion on the welfare of a verte-
brate species depend on the number of animals affected, the
duration of their suffering and the severity of that suffering.
Presently, when a novel pesticide is submitted for registra-
tion, information on the suffering associated with sub-lethal
intoxication in the target species is not explicitly required in
the UK (CRD 2012), but it could be important if that
suffering is protracted and common. From this background,
in a series of experiments the behaviour of sub-lethally
PAVP-poisoned rats and the duration and nature of effects
was examined. Firstly, adult female rats were dosed with
30 mg kg–1 PAVP (based on a preliminary LD50 estimate of
30–50 mg kg–1), and the concentration of circulating MetHb
was measured in order to determine the acute MetHb profile
over time. Secondly, a refined LD50 estimate for PAVP in
adult female rats was obtained; this estimate was used for
subsequent sub-lethal trials. Thirdly, three neurological tests
(grip strength, inclined plane and tape removal) were
developed and validated using untreated adult female rats.
Finally, 20 adult female rats were dosed with 40 mg kg–1
PAVP (based on the revised LD50) (plus ten controls) and
survivors were assessed using the three neurological tests to
look for any impacts of sub-lethal PAVP poisoning on
sensorimotor and neurological function.
The refined estimate of acute oral LD50 was 42.2 mg kg–1
for PAVP in female rats, which is similar to that of other
acute rodenticides, such as zinc phosphide (Dieke & Richter
1946; Hood 1972). Para-aminovalerophenone therefore
appears to be sufficiently toxic to be a candidate rodenti-
cide, but as with other acute toxins, the rapid mode of action
is an undesirable property. The onset of signs of toxicosis
Animal Welfare 2015, 24: 427-436
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Figure 5
Mean (± SEM) angle at which rats began
to slip on a board that was raised at one
end to form an inclined plane. The
starting angle was ≥ 30°.
Figure 6
Mean (± SEM) food consumption (g) by
adult female rats treated with 40 mg kg–1
PAVP relative to untreated controls.
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was accompanied by a temporary suppression in food
uptake; this effect would likely lead to reduced levels of bait
consumption (discussed in more detail in Gibson et al 2015;
this issue) and potential for sub-lethal poisoning. As with
other acute (fast-acting) rodenticides, these issues could be
at least partly mitigated by pre-baiting, or even microencap-
sulation to delay onset of toxicosis. Without further work
(including feeding trials), it is not possible to estimate the
number of animals likely to be affected by sub-lethal
poisoning from use of PAVP as a rodenticide; in the field
bait uptake depends on many factors including stability of
the environment and the availability of alternative food
(Quy et al 1992, 1994) and also the feeding behaviour of
individual rats (Quy et al 2003). The current study therefore
aimed to examine the duration and severity of the effects of
sub-lethal PAVP poisoning. 
Following dosing with PAVP, the onset of toxicosis was rapid,
with cyanosis within 5 min and behavioural changes apparent
within 30 min, following a similar sequence as reported by
Gibson et al (2015; this issue). However, recovery of survivors
following sub-lethal dosing was also relatively fast, and by day
two all were rated as normal in subjective visual assessments.
In the grip strength test, there was no evidence that the
performance of sub-lethally poisoned rats was impaired
relative to untreated controls, and there was no evidence of an
improvement in performance over time for either group. 
On the tape removal test, performance of sub-lethally
poisoned and control rats improved over time, but there was
no overall significant treatment effect. There was also no
interaction between time and treatment group, suggesting
that there was no significant difference in the change in
response over time between groups; both groups therefore
demonstrated a similar rate of learning in this task.
However, four rats in the treated group failed to complete
the task within the default time limit of 3 min (two on day
one and one on days four and seven). These rats were
assigned a default time (of 3 min) in the analyses, on the
basis that all ‘normal’ rats should complete the task within
this time limit (Albertsmeier et al 2007). Assigning a default
value potentially biases the result, as would excluding these
animals from the analyses. The number of rats assigned a
default value was relatively small (4 of 147 data-points) and
it is therefore unlikely that there was a significant bias. It is
important to note that the lack of statistical significance
does not necessarily demonstrate the lack of a subtle biolog-
ical response. Furthermore, it is possible that more subtle
differences would have been detected if tape had been
applied to both paws to test for asymmetry in brain
malfunctions (Schallert & Whishaw 1984). Some subtle
differences between treated and control rats were also found
during the inclined plane test (impaired performance of
treated rats relative to controls on day two) indicating
potential impairment in the functions of the frontal motor
cortex. While the rats were always tested in the head-up
orientation, testing left- or right-side up might have been
more discriminatory (Yonemori et al 1998). However, intu-
itively, in sternally recumbent animals (which was the
normal posture during acute methaemoglobinaemia) it
would be expected that methaemoglobinaemia would lead
to a global rather than a focal or lateral cerebral hypoxaemia
and thus which paw was taped or the orientation of the rat
was immaterial. In validations of the three neurological tests
using untreated female animals, the reproducibility of the
inclined plane and grip strength tests was lower (as demon-
strated by the lower ICC for individual days compared to an
average response measured over four days) than for the tape
removal test, suggesting that the tape removal test was
likely to give less variable (and hence potentially more
reliable) results than the other two tests. 
The authors could find no other similar empirical studies of
the effects of sub-lethal rodenticide poisoning in rats by
which the current results could be compared with. However,
there have been several reviews comparing the relative
humaneness of different vertebrate control techniques. These
conclude that lethal doses of anticoagulant rodenticides are
associated with protracted deaths, distress, disability and/or
pain; they also concluded that animals sub-lethally poisoned
with anticoagulant rodenticides are likely to experience
haemorrhages and their sequelae (Mason & Littin 2003;
Fisher et al 2010; Sharp & Saunders 2011). Very protracted
effects of anticoagulant sub-lethal poisoning have been
documented in humans, particularly for the most toxic (and
persistent) anticoagulants such as brodifacoum and
flocoumafen, with symptoms sometimes lasting several
months (Hui et al 1996; Gunja et al 2011). Persistence of
PAPP analogues appears to be much less than for anticoagu-
lants; a half-life of 2.5–8.5 h in dogs has been reported
(Baskin & Fricke 1992) compared to 220 days for
flocoumafen in rat liver tissue (Huckle et al 1989). The
duration of sub-lethal PAVP poisoning effects is therefore
likely to be lower than that of anticoagulants. In the current
study after sub-lethal poisoning with PAVP, outward visual
signs of behavioural impairment lasted less than 48 h, and
there was no evidence that neurological functions were
impaired beyond seven days. Mason and Littin (2003) also
concluded that the acute rodenticides zinc phosphide and
calciferol are also generally inhumane; the former typically
causing severe pain for several hours, and the latter pain and
illness for several days. Morgan and Milne (2002) recorded
a depression of appetite that lasted for 7–15 days in brushtail
possums following sub-lethal poisoning with cholecalcif-
erol, while Prescott et al (1992) reported a reduction in body-
weight over the first seven days of recovery following
ingestion of cholecalciferol baits by laboratory rats.
Following sub-lethal PAVP toxicosis there was no overall
difference in food consumption and increase in bodyweight
between treated and control rats over 14 days.
The evidence from the neurological tests suggests that the rats
were able to survive relatively high levels of MetHb (55–67%
for ≥ 4 h) in their blood and make a full recovery without any
permanent impairment. The tests appeared sensitive enough
to detect subtle changes in behaviour that would probably not
be detected by casual observations of animals post-treatment.
During the tests, the treated animals responded normally to
handling with no apparent signs of pain in limbs or body. The
findings from this study and the accompanying paper by
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Gibson et al (2015; this issue) indicates that the severity and
duration of signs following acute lethal and sub-lethal PAVP
poisoning appear to be substantially less than that caused by
existing rodenticide compounds. 
Many millions of rodents are killed each year as pests
(Mason & Littin 2003) and use of rodenticides (particularly
anticoagulants) is often cited as the most commonly used
method of control (eg Witmer et al 2007; Laasko et al 2010).
Given the potential numbers of animals involved, it seems
slightly surprising that more data do not exist on the compar-
ative humaneness of different rodenticide compounds, and
that welfare considerations do not routinely form part of the
initial phase of the rodenticide evaluation and registration
process. Potentially, the methods presented here could form
the framework for such future evaluations. 
Animal welfare implications and conclusion
It is concluded that sub-lethal poisoning of rats by PAVP
resulted in substantial changes in behaviour (reduced
movement and responsiveness to external stimuli) lasting
for between 24 and 48 h (all PAVP sub-lethally treated rats
were rated as normal by day two). More prolonged, but
subtle, differences were detected by behavioural tests;
performance of treated rats on an inclined plane test was
impaired relative to untreated controls on day two, and on
four of 77 occasions (up to day seven), treated rats failed to
remove tape applied to the front paw within a 3-min time
limit. These results, combined with those of the accompa-
nying paper (Gibson et al 2015; this issue), suggest that the
effects of sub-lethal PAVP poisoning are less severe and
prolonged than those reported for the anticoagulants. 
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